A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors | MicrobiomeTrials← Back to trialsNCT07287995
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2026-02-05Est. Completion: 2029-06-30
Enrollment target: 428 participants Locations- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States
- START New York Long Island, New Hyde Park, New York, United States
- Tennessee Oncology, Nashville, Tennessee, United States
- NEXT Virginia, Fairfax, Virginia, United States
- National Cancer Center Hospital East, Kashiwa-shi, Chiba, Japan
- National Cancer Center Hospital, Chuo-ku, Tokyo, Japan
- The Cancer Institute Hospital of JFCR, Koto-ku, Tokyo, Japan
Other microbiome trials you might be interested in
Advanced Esophageal Squamous Cell CarcinomaAdvanced Renal Cell CarcinomaClinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage IIB Cutaneous Melanoma AJCC v8Clinical Stage IIC Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8Esophageal CarcinomaGastroesophageal Junction AdenocarcinomaHepatocellular CarcinomaLocally Advanced Urothelial CarcinomaLung Non-Small Cell CarcinomaMalignant Solid NeoplasmMetastatic Colorectal CarcinomaMetastatic Cutaneous MelanomaMetastatic Esophageal Squamous Cell CarcinomaMetastatic Head and Neck Squamous Cell CarcinomaMetastatic Urothelial CarcinomaRecurrent Esophageal Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell CarcinomaRenal Cell CarcinomaStage III Renal Cell Cancer AJCC v8Stage IV Colorectal Cancer AJCC v8Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8Stage IV Renal Cell Cancer AJCC v8Unresectable Cutaneous MelanomaUnresectable Esophageal Squamous Cell CarcinomaUrothelial CarcinomaUnresectable Urothelial Carcinoma
This phase II trial compares the impact of subcutaneous (SC) nivolumab given in an in-home setting to an in-clinic setti…
Jacksonville, United StatesEst. completion Dec 31, 2026
Solid TumorsNeoplasms (Cancer / Tumors)Advanced Malignant Solid NeoplasmLocally Advanced Malignant Solid NeoplasmUnresectable Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmHER2 ExpressionBiliary Tract NeoplasmsEndometrial NeoplasmsUrothelial Carcinoma (UC)Pancreatic NeoplasmsColorectal NeoplasmsGastric NeoplasmsNon-Small Cell Lung Carcinoma (NSCLC)Head and Neck NeoplasmsCervical Neoplasms
The goal of this clinical trial is to learn if Trastuzumab Rezetecan can treat advanced solid tumors with HER-2 expressi…
Multiple Locations
Est. completion Dec 31, 2028